Daily Current Affairs / DCGI approves two clinical trials of indigenous Covid vaccine Corbevax
Category : National Published on: September 04 2021
· The Drug Controller General of India- DCGI has approved two clinical trials of indigenous Covid vaccine Corbevax.
· Vaccine maker Biologicals E has received permission for Phase II and III trials on children between the ages of five and eighteen under certain conditions.
· The Department of Biotechnology and its PSU Biotechnology Industry Research Assistance Council – BIRAC have provided support to Biologicals E's COVID-19 Vaccine.
· This support will be provided from the preclinical phase to the third phase of the trial.
Important facts
About the DCGI
v DCGI: Drugs Controller General of India
v Headquarters location: New Delhi
Digital India BHASHINI Division signed an MoU with Survey of India on 20 January 2026 to digitise and standardise geographical names using AI technology.
Read More....Vice President C. P. Radhakrishnan released the book “Chalice of Ambrosia: Ram Janmabhoomi – Challenge and Response” in New Delhi.
Read More....India sent 7.5 tonnes of life-saving cancer medicines to Afghanistan as part of healthcare cooperation.
Read More....Tata Communications appointed Ganesh Lakshminarayanan as its Managing Director and CEO-Designate.
Read More....Bharat Rang Mahotsav 2026, the world’s largest theatre festival, is being held across 40 locations in India featuring 277 productions including Indian and international plays in 228 languages.
Read More....The film Sinners became the first movie to receive 16 Oscar nominations.
Read More....Timothée Chalamet became the youngest actor to receive three Best Actor Oscar nominations.
Read More....Telangana secured a ₹5,000 crore AI data centre investment at WEF 2026.
Read More....The United States officially completed its withdrawal from the World Health Organization.
Read More....Odisha imposed a complete ban on gutkha, pan masala and all tobacco products from February 1, 2026.
Read More....